First generation antipsychotics (FGAS), also known as conventional antipsychotics, are categorized by low potency, medium potency, and high potency. Which of the following medications fall into the FGA high potency classification?

Transdermal opioid therapy using agents such as Fentanyl is commonly used for the management of chronic, severe pain requiring continuous opioid delivery. The patch provides steady systemic absorption over a prolonged period, avoiding peaks and troughs associated with oral dosing. Safe use requires strict adherence to dosing intervals, proper application techniques, and avoidance of misuse. Patient and family education is essential to prevent overdose, withdrawal, or inadequate pain control.

Rationale:
A. Applying the patch to the chest only is incorrect because fentanyl patches can be applied to multiple flat, non-irritated, hairless areas of the upper body or upper arm. Rotating application sites helps prevent skin irritation and ensures consistent absorption. Restricting application to only the chest unnecessarily limits appropriate use.

B. Removing the patch daily and cleaning the skin is incorrect because fentanyl patches are designed for extended-release over 72 hours. Daily removal would prevent adequate drug delivery and result in uncontrolled pain. Skin should be cleaned before application, but the patch should remain in place for the full prescribed duration.

C. Applying it for breakthrough pain is incorrect because transdermal fentanyl is intended for continuous baseline pain control, not acute or breakthrough pain episodes. Breakthrough pain requires short-acting analgesics for rapid relief. Using the patch in this way can lead to delayed onset of action and potential overdose risk.

D. The fentanyl patch is typically replaced every 72 hours (every 3 days), ensuring continuous and stable analgesia. This dosing schedule maintains therapeutic drug levels while minimizing fluctuations. Proper adherence to this interval is essential for safe and effective long-term pain management.

Acute changes in mental status accompanied by autonomic instability and neuromuscular abnormalities after initiation of serotonergic medications suggest a life-threatening condition, serotonin toxicity. Serotonin syndrome occurs due to excessive serotonergic activity in the central nervous system, often shortly after starting or increasing doses of SSRIs. Clinical features include agitation, confusion, hyperthermia, tremors, muscle rigidity, and autonomic dysregulation such as diaphoresis. Rapid recognition and immediate discontinuation of the causative agent are critical to prevent progression to severe toxicity or death.

Rationale:
A. Adding an MAOI is dangerous and would significantly worsen the condition. Monoamine oxidase inhibitors further increase serotonin levels and can precipitate severe, potentially fatal serotonin toxicity when combined with SSRIs. This contradicts safe management principles and would intensify symptoms such as hyperthermia, rigidity, and autonomic instability.

B. Decreasing the dose of fluoxetine is inappropriate in an acute toxic reaction. Serotonin syndrome is not dose-managed but requires immediate cessation of the offending agent. Dose reduction would still allow ongoing serotonergic excess and could delay critical intervention, increasing the risk of complications such as seizures or organ failure.

C. An allergic reaction is unlikely because the symptoms described are not consistent with histamine-mediated hypersensitivity. There is no evidence of urticaria, airway swelling, or anaphylaxis. Instead, the combination of agitation, tremor, hyperreflexia, and muscle spasms strongly indicates a toxic serotonergic state rather than an immunologic reaction.

D. Immediate discontinuation of Fluoxetine is the priority intervention in serotonin syndrome. Removing the serotonergic agent stops further accumulation of serotonin activity in the central nervous system. Supportive care, sedation, and close monitoring are also required to stabilize autonomic and neuromuscular symptoms and prevent progression to severe complications.